融捷健康
(300247)
| 流通市值：30.28亿 | | | 总市值：30.31亿 |
| 流通股本：8.03亿 | | | 总股本：8.04亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 253,073,511.75 | 180,323,534.41 | 207,604,897.83 | 209,490,134.39 |
| 应收票据及应收账款 | 66,917,173.84 | 72,624,486.81 | 51,828,501.46 | 45,628,292.88 |
| 应收账款 | 66,917,173.84 | 72,624,486.81 | 51,828,501.46 | 45,628,292.88 |
| 应收款项融资 | - | 10,000 | - | - |
| 预付款项 | 5,325,108.53 | 10,911,150.4 | 7,839,055.18 | 8,902,732.78 |
| 其他应收款合计 | 4,871,058.23 | 2,783,418.04 | 2,894,856.04 | 2,891,379.78 |
| 存货 | 153,572,567.3 | 178,264,476.3 | 179,152,113.54 | 143,590,254.17 |
| 一年内到期的非流动资产 | 10,970,725.99 | 10,885,657.5 | - | - |
| 其他流动资产 | 118,283,828.27 | 101,083,471.41 | 134,096,348.79 | 164,680,270.14 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 979,800,735.43 | 947,370,678.98 | 876,055,455.28 | 868,249,411.2 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 35,137,296.95 | 35,137,296.95 | 35,137,296.95 | 35,137,296.95 |
| 其他非流动金融资产 | 15,783,384.96 | 15,783,384.96 | 15,783,384.96 | 15,783,384.96 |
| 投资性房地产 | 56,892,681.38 | 56,892,681.38 | 64,595,389.26 | 64,595,389.26 |
| 固定资产 | 199,279,000.48 | 200,558,955.03 | 202,490,726.46 | 205,123,265.95 |
| 在建工程 | 626,241.48 | 541,592.94 | 1,020,022.03 | 978,871.59 |
| 使用权资产 | 733,101.84 | 4,119,041.4 | 6,712,747.17 | 9,838,226.27 |
| 无形资产 | 39,642,403.11 | 40,568,932.94 | 40,679,949.63 | 41,420,676.19 |
| 长期待摊费用 | 702,351.57 | 191,311.33 | 197,405.68 | 262,517.32 |
| 递延所得税资产 | 1,305,230.6 | 1,307,085.29 | 5,088,561.91 | 5,807,597.52 |
| 其他非流动资产 | 707,947.84 | 707,947.84 | 11,301,752.11 | 11,214,793.21 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 350,809,640.21 | 355,808,230.06 | 383,007,236.16 | 390,162,019.22 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,330,610,375.64 | 1,303,178,909.04 | 1,259,062,691.44 | 1,258,411,430.42 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 61,012,999.1 | 58,698,257.52 | 59,555,575.7 | 54,848,551.72 |
| 应付账款 | 61,012,999.1 | 58,698,257.52 | 59,555,575.7 | 54,848,551.72 |
| 合同负债 | 24,718,927.7 | 22,068,687.93 | 20,014,251.3 | 20,886,028.36 |
| 应付职工薪酬 | 15,734,034.05 | 30,260,509.28 | 17,497,203.92 | 15,192,406.61 |
| 应交税费 | 16,593,243.79 | 6,246,586.52 | 8,720,018.84 | 16,145,747.67 |
| 其他应付款合计 | 9,046,226.88 | 20,360,785.64 | 7,213,962.9 | 7,633,300 |
| 一年内到期的非流动负债 | 2,054,708.31 | 5,442,525.83 | 8,266,141.15 | 11,418,088.73 |
| 其他流动负债 | 527,278.96 | 1,677,606.56 | 1,395,430.96 | 1,352,357.52 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 129,687,418.79 | 144,754,959.28 | 122,662,584.77 | 127,476,480.61 |
| 非流动负债: | | | | |
| 递延所得税负债 | 16,579,017.67 | 16,600,112.68 | 17,128,939.02 | 17,805,157.26 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 16,579,017.67 | 16,600,112.68 | 17,128,939.02 | 17,805,157.26 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 146,266,436.46 | 161,355,071.96 | 139,791,523.79 | 145,281,637.87 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 804,040,313 | 804,040,313 | 804,040,313 | 804,040,313 |
| 资本公积 | 1,345,550,547.35 | 1,345,550,547.35 | 1,345,550,547.35 | 1,345,550,547.35 |
| 其他综合收益 | 46,793,565.78 | 47,132,621.95 | 42,822,611.46 | 45,297,881.89 |
| 盈余公积 | 22,193,765.4 | 22,193,765.4 | 22,193,765.4 | 22,193,765.4 |
| 未分配利润 | -1,122,242,538.62 | -1,153,226,708.53 | -1,163,644,100.91 | -1,171,404,404.62 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,096,335,652.91 | 1,065,690,539.17 | 1,050,963,136.3 | 1,045,678,103.02 |
| 少数股东权益 | 88,008,286.27 | 76,133,297.91 | 68,308,031.35 | 67,451,689.53 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,184,343,939.18 | 1,141,823,837.08 | 1,119,271,167.65 | 1,113,129,792.55 |
| 负债和股东权益合计 | 1,330,610,375.64 | 1,303,178,909.04 | 1,259,062,691.44 | 1,258,411,430.42 |
| 公告日期 | 2025-04-25 | 2025-04-23 | 2024-10-25 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |